|
|
|
Thursday, 17 April 2008 |
Innocoll's Gentamicin Topical new human study commences
|
|
Wednesday, 16 April 2008 |
Zelos and Aegis sign deal for Intravail(R) technology
|
|
Monday, 14 April 2008 |
Jazz launches Luvox(R) CR
|
|
Monday, 14 April 2008 |
Oramed starts phase 2a for oral insulin
|
|
Monday, 14 April 2008 |
sNDA for RISPERDAL(R) CONSTA(R)
|
|
Wednesday, 09 April 2008 |
Nektar terminates insulin programs
|
|
Tuesday, 08 April 2008 |
Iomai receives grant to develop anthrax vaccine
|
|
Tuesday, 08 April 2008 |
Aradigm starts trial using AERx technology
|
|
Monday, 07 April 2008 |
Endo to return rights to CHRONOGESIC(R)
|
|
Friday, 04 April 2008 |
Abraxis acquires Shimoda Biotech
|
|
Thursday, 03 April 2008 |
Iomai and Merck enter agreement to evaluate patch
|
|
Thursday, 03 April 2008 |
Indevus licenses VANTAS(R) to Orion
|
|
Wednesday, 02 April 2008 |
Abraxis commences phase 2 of Coroxane(TM)
|
|
Tuesday, 01 April 2008 |
Vivus reaches SPA agreement for Luramist(TM)
|
|
Monday, 31 March 2008 |
Elite Pharmaceuticals updates data on pain products
|
|
Monday, 31 March 2008 |
Acusphere licences HDDS(TM) to Cephalon
|
|
Monday, 31 March 2008 |
QLT starts phase 2 study for punctal plug drug delivery system
|
|
Monday, 31 March 2008 |
Teva will acquire Bentley
|
|
Thursday, 27 March 2008 |
Avanti launches a new drug delivery company
|
|
Thursday, 27 March 2008 |
IntelliPharmaCeutics completes clinical trial on ReXista(TM)
|
|
Wednesday, 26 March 2008 |
Alexza forms subsidiary in Singapore
|
|
Monday, 24 March 2008 |
Depomed starts phase 3 study of Gabapentin GR(TM)
|
|
Monday, 24 March 2008 |
Zogenix files for IPO
|
|
Monday, 24 March 2008 |
Biovail settles case with SEC
|
|
Wednesday, 19 March 2008 |
Abbott receives rights to Lupron Depot(R)
|
|
Wednesday, 19 March 2008 |
Emisphere updates data on oral B12
|
|
Wednesday, 19 March 2008 |
BioSante initiates third phase 3 study for LibiGel(R)
|
|
Wednesday, 19 March 2008 |
Alkermes restructures operations
|
|
Tuesday, 18 March 2008 |
Alimera and pSivida amend deal on Medidur(TM)
|
|
Tuesday, 18 March 2008 |
DiObex and Camurus sing license agreement
|
|
Monday, 17 March 2008 |
NanoBio completes phase 2 trial of NB-001
|
|
Monday, 17 March 2008 |
FDA reviews QLT's Aczone(TM)
|
|
Monday, 17 March 2008 |
Baxter presents clinical results of subcutaneous GAMMAGARD LIQUID(TM)
|
|
Thursday, 13 March 2008 |
Silence Therapeutics and AstraZeneca to collaborate
|
|
Thursday, 13 March 2008 |
Innocoll commences second phase 2 trial of surgical implant
|
|
Wednesday, 12 March 2008 |
Celsion starts phase 3 for ThermoDox(R)
|
|
Tuesday, 11 March 2008 |
Abbott receives CE Mark for 2.25 mm XIENCE(TM) V DES
|
|
Tuesday, 11 March 2008 |
Inovio reports data on malignant melanoma study
|
|
Tuesday, 11 March 2008 |
Cerner and UNM enter deal to evaluate a DPI
|
|
Monday, 10 March 2008 |
Halozyme presents PK data on new manufacturing process
|
|
Friday, 07 March 2008 |
AVANT and Celldex complete merger
|
|
Friday, 07 March 2008 |
Lilly terminates inhaled insulin agreement with Alkermes
|
|
Thursday, 06 March 2008 |
Penwest announces private placement
|
|
Thursday, 06 March 2008 |
NanoBio receives funding
|
|
Wednesday, 05 March 2008 |
Notice from NASDAQ to Hana Biosciences
|
|
Tuesday, 04 March 2008 |
Debio moves Debio 9902 SR forward
|
|
Monday, 03 March 2008 |
MicroDose and Merck & Co. sign a deal
|
|
Thursday, 28 February 2008 |
Not approvable letter for Lilly's Zyprexa(R) LAI
|
|
Thursday, 28 February 2008 |
Arriva receives financing from Nordic Biotech
|
|
Wednesday, 27 February 2008 |
NeurogesX reports results from phase 3 study of NGX-4010
|
| |
|
Results 1 - 50 of 185 |
